CGON (STOCKS)
CG Oncology, Inc. Common stock
$74.710000
-2.280000 (-2.96%)
Prev close: $76.990000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Arthur Kuan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7,367.22M
- Employees
- 113
- P/E (TTM)
- -28.56
- P/B (TTM)
- 6.61
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
14
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.90 | $-0.68 | -0.2224 | -32.82% |
|
Mar 2026 (Q1)
|
$-0.71 | $-0.58 | -0.1329 | -23.03% |
|
Dec 2025 (Q4)
|
$-0.53 | $-0.63 | +0.0967 | +15.43% |
|
Sep 2025 (Q3)
|
$-0.57 | $-0.57 | +0.0012 | +0.21% |
Financial Statements
| Revenues | $6.23M |
| Benefits Costs and Expenses | -$60.12M |
| Costs And Expenses | $275.05M |
| Nonoperating Income/Loss | $28.24M |
| Operating Expenses | $258.85M |
| Research and Development | $156.23M |
| Other Operating Expenses | $102.62M |
| Operating Income/Loss | -$252.62M |
| Income/Loss From Continuing Operations After Tax | -$224.38M |
| Income/Loss From Continuing Operations Before Tax | -$13.87M |
| Net Income/Loss | -$224.38M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$224.38M |
| Net Income/Loss Available To Common Stockholders, Basic | -$224.38M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.69 |
| Diluted Earnings Per Share | -$2.69 |
| Basic Average Shares | 250,368,325 |
| Diluted Average Shares | 250,368,325 |
| Assets | $1.09B |
| Current Assets | $1.05B |
| Accounts Receivable | $417.00K |
| Inventory | $1.00M |
| Other Current Assets | $1.05B |
| Noncurrent Assets | $36.01M |
| Fixed Assets | $14.71M |
| Other Non-current Assets | $21.30M |
| Liabilities | $56.54M |
| Current Liabilities | $47.24M |
| Accounts Payable | $12.73M |
| Other Current Liabilities | $34.51M |
| Noncurrent Liabilities | $9.30M |
| Equity | $1.03B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.03B |
| Liabilities And Equity | $1.09B |
| Net Cash Flow From Operating Activities | -$178.47M |
| Net Cash Flow From Operating Activities, Continuing | -$178.47M |
| Net Cash Flow From Investing Activities | -$364.88M |
| Net Cash Flow From Investing Activities, Continuing | -$364.88M |
| Net Cash Flow From Financing Activities | $548.36M |
| Net Cash Flow From Financing Activities, Continuing | $548.36M |
| Net Cash Flow | $5.01M |
| Net Cash Flow, Continuing | $5.01M |
| Comprehensive Income/Loss | -$224.38M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$224.38M |
| Other Comprehensive Income/Loss | $0.00 |